Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia.
Himalee S SabnisCaroline KeenumRebecca W LewisBriana PattersonJohn BergsagelKaren E EffingerEmily SilvermanAnn C MertensSharon M CastellinoPublished in: British journal of haematology (2018)